EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ANAB: Anaptysbio Inc

10 Nov 25 17:55
LAST:

33.98

CHANGE:
 5.67		OPEN:
32.00		HIGH:
35.80		ASK:
14.39		VOLUME:
2.13M
CHG(%):
14.30		PREV:
39.65		LOW:
30.27		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 2532.0035.8030.2733.982.13M
07 Nov 2538.0039.7936.3639.65377.8K
06 Nov 2536.0040.9635.9138.20741.7K
05 Nov 2539.2239.7834.2136.00774.7K
04 Nov 2535.9736.5034.6034.74242.9K
03 Nov 2536.2137.1235.5436.04314.0K
31 Oct 2536.4036.9636.0336.58229.8K
30 Oct 2536.0537.8036.0536.47320.0K
29 Oct 2537.9138.3935.8236.12554.0K
28 Oct 2536.1437.0035.9636.16226.5K

COMPANY PROFILE

Name:Anaptysbio Inc
About:AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:10770 Wateridge Circle, San Diego, CA, United States, 92121-5801
Website:https://www.anaptysbio.com
CUSIP:032724106
CIK:0001370053
ISIN:US0327241065
FIGI:BBG0026ZDHR0
LEI:529900HH4WQT03IG1A12

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-7.04 
Forward P/E:-5.71 
PEG Ratio:0.33 
Price to Sales:8.31 
Price to Book:-23.21 
Profit Margin:-1.08 
Operating Margin:-1.18 
Return on Assets:-0.14 
Return on Equity:-2.05 
EPS Ratio:-4.39 
Revenue:123.16M 
Shares:27.97M 
Market Cap:950.52M 

TECHNICAL INDICATORS

MA5:36.517.5%
MA10:36.397.1%
MA20:35.374.1%
MA50:29.0916.8%
MA100:26.1929.8%
MA200:22.6849.8%
STO14:4.51 
RSI14:49.59
WPR14:-94.50 
MTM14:0.33
ROC14:0.01 
ATR:2.80 
Week High:40.9620.5%
Week Low:30.2712.3%
Month High:40.9620.5%
Month Low:30.2749.8%
Year High:40.9620.5%
Year Low:12.21178.3%
Volatility:9.97